Mallinckrodt's bankruptcy permitted the drug company to end a perpetual royalty agreement with Sanofi-Aventis involving the ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

However, some of Mallinckrodt’s non-opioid drug businesses have struggled since it left bankruptcy, including sales of specialty drugs like Acthar Gel. In the second quarter, Mallinckrodt also ...

H.P. Acthar Gel (Acthar), from 2009 to 2013. The company is already facing $5 billion in debt, according to Bloomberg.

And, some of these drugs have active ingredients that are very old, as is the case with Synthroid (levothyroxine), Makena (hydroxyprogesterone caproate), and Acthar Gel (corticotropin).

The Ireland-domiciled company was accused of illegally paying smaller drug rebates to Medicaid than were due, as well as using a charitable foundation to cover co-pays for its Acthar Gel ...

The company's primary product is H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations ...

Exceeds High End of Guidance Range on Net Sales and Adjusted EBITDA for Fiscal Year Received U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application for Acthar ® Gel ...